Tomaralimab (OPN-305) 是一种人源化的抗-TLR2 (anti-TLR2) IgG4 单克隆抗体。Tomaralimab 具有研究骨髓增生异常综合征 (MDS) 的潜力。
| 生物活性 | Tomaralimab (OPN-305) is a humanisedanti-TLR2IgG4monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS)[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
